The usefulness of mesenchymal stem cells beyond the musculoskeletal system in horses

Cequier, A. (Universidad de Zaragoza) ; Sanz, C. ; Rodellar, C. (Universidad de Zaragoza) ; Barrachina, L. (Universidad de Zaragoza)
The usefulness of mesenchymal stem cells beyond the musculoskeletal system in horses
Resumen: The differentiation ability of mesenchymal stem cells (MSCs) initially raised interest for treating musculoskeletal injuries in horses, but MSC paracrine activity has widened their scope for inflammatory and immune-mediated pathologies in both equine and human medicine. Further-more, the similar etiopathogenesis of some diseases in both species has advanced the concept of “One Medicine, One Health”. This article reviews the current knowledge on the use of MSCs for equine pathologies beyond the locomotor system, highlighting the value of the horse as translational model. Ophthalmologic and reproductive disorders are among the most studied for MSC application. Equine asthma, equine metabolic syndrome, and endotoxemia have been less explored but offer an interesting scenario for human translation. The use of MSCs in wounds also provides a potential model for humans because of the healing particularities in both species. High-burden eq-uine-specific pathologies such as laminitis have been suggested to benefit from MSC-therapy, and MSC application in challenging disorders such as neurologic conditions has been proposed. The available data are preliminary, however, and require further development to translate results into the clinic. Nevertheless, current evidence indicates a significant potential of equine MSCs to enlarge their range of application, with particular interest in pathologies analogous to human conditions.
Idioma: Inglés
DOI: 10.3390/ani11040931
Año: 2021
Publicado en: Animals 11, 4 (2021), 931 [28 pp]
ISSN: 2076-2615

Financiación: info:eu-repo/grantAgreement/ES/MINECO/AGL2017-84411-P
Tipo y forma: Revisión (Versión definitiva)
Área (Departamento): Área Genética (Dpto. Anatom.,Embri.Genét.Ani.)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.

Exportado de SIDERAL (2021-06-03-11:43:38)

Este artículo se encuentra en las siguientes colecciones:

 Registro creado el 2021-06-03, última modificación el 2021-06-03

Versión publicada:
Valore este documento:

Rate this document:
(Sin ninguna reseña)